Inventor · disambiguated record
Satoshi Shimizu
Also filed as: SHIMIZU SATOSHI
14 granted patents·11 pending applications·79 citations·filing 2006–2024
92Inventor score
Files withOTSUKA PHARMA CO LTD17MOCHIDA PHARM CO LTD4KAKEHI KAZUAKI1SUZUKI MASAKI1UNIV HOKKAIDO NAT UNIV CORP1
Top patents by PatentIndex Score
25 records- 0197US7888362B2Piperazine-substituted benzothiophenes for treatment of mental disordersOTSUKA PHARMA CO LTD·Filed 2006·Granted Feb 15, 2011·22 cites·9 claims
- 0292US8349840B2Piperazine-substituted benzothiophenes for treatment of mental disordersOTSUKA PHARMA CO LTD·Filed 2010·Granted Jan 8, 2013·11 cites·6 claims
- 0390US8618109B2Piperazine-substituted benzothiophenes for treatment of mental disordersOTSUKA PHARMA CO LTD·Filed 2012·Granted Dec 31, 2013·8 cites·3 claims
- 0486US9480686B2Piperazine-substituted benzothiophenes for treatment of mental disordersOTSUKA PHARMA CO LTD·Filed 2015·Granted Nov 1, 2016·3 cites·4 claims
- 0586US9073890B2Therapeutic compounds and related methods of useSUZUKI MASAKI·Filed 2010·Granted Jul 7, 2015·11 cites·7 claims
- 0685US9839637B1Piperazine-substituted benzothiophenes for treatment of mental disordersOTSUKA PHARMA CO LTD·Filed 2017·Granted Dec 12, 2017·2 cites·18 claims
- 0784US9206167B2Piperazine-substituted benzothiophenes for treatment of mental disordersOTSUKA PHARMA CO LTD·Filed 2013·Granted Dec 8, 2015·3 cites·4 claims
- 0884US8071600B2Derivatives of 4-piperazin-1-yl-4-benzo[B]thiophene suitable for the treatment of CNS disordersYAMASHITA HIROSHI·Filed 2006·Granted Dec 6, 2011·7 cites·14 claims
- 0979US8993536B2Low-molecular polysulfated hyaluronic acid derivative and medicine containing sameKAKEHI KAZUAKI·Filed 2010·Granted Mar 31, 2015·10 cites·20 claims
- 1077US9630947B2Therapeutic compounds and related methods of useOTSUKA PHARMA CO LTD·Filed 2015·Granted Apr 25, 2017·2 cites·8 claims
- 1177US2021113556A1Piperazine-Substituted Benzothiophenes For Treatment of Mental DisordersOTSUKA PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 1274US2020237755A1Piperazine-Substituted Benzothiophenes For Treatment of Mental DisordersOTSUKA PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 1374US2025032681A1Anti-adhesion compositionMOCHIDA PHARM CO LTD·Filed 2024·Application pending·0 cites
- 1473US2019321359A1Piperazine-Substituted Benzothiophenes For Treatment of Mental DisordersOTSUKA PHARMA CO LTD·Filed 2019·Application pending·0 cites
- 1572US2019117648A1Piperazine-Substituted Benzothiophenes For Treatment of Mental DisordersOTSUKA PHARMA CO LTD·Filed 2018·Application pending·0 cites
- 1669US2018214444A1Piperazine-Substituted Benzothiophenes For Treatment of Mental DisordersOTSUKA PHARMA CO LTD·Filed 2017·Application pending·0 cites
- 1767US2017231983A1Piperazine-Substituted Benzothiophenes For Treatment of Mental DisordersOTSUKA PHARMA CO LTD·Filed 2017·Application pending·0 cites
- 1866USRE48059EPiperazine-substituted benzothiophenes for treatment of mental disordersOTSUKA PHARMA CO LTD·Filed 2006·Granted Jun 23, 2020·0 cites·15 claims
- 1965US2017000786A1Piperazine-Substituted Benzothiophenes For Treatment of Mental DisordersOTSUKA PHARMA CO LTD·Filed 2016·Application pending·0 cites
- 2063US11890145B2Adhesion-preventing compositionMOCHIDA PHARM CO LTD·Filed 2022·Granted Feb 6, 2024·0 cites·9 claims
- 2155US2014031334A1Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disordersOTSUKA PHARMA CO LTD·Filed 2013·Application pending·0 cites
- 2252US11464597B2Adhesion-preventing compositionMOCHIDA PHARM CO LTD·Filed 2017·Granted Oct 11, 2022·0 cites·22 claims
- 2352US2020397954A1Anti-adhesion compositionMOCHIDA PHARM CO LTD·Filed 2018·Application pending·0 cites
- 2451US2017217923A1Therapeutic compounds and related methods of useOTSUKA PHARMA CO LTD·Filed 2017·Application pending·0 cites
- 2541US12478636B2Composition for treating intervertebral discUNIV HOKKAIDO NAT UNIV CORP·Filed 2017·Granted Nov 25, 2025·0 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when Satoshi Shimizu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →